BankNordik has announced 2023 net profit guidance of DKK 190-220m, alongside a revision of its 2024 ...
Cons. expects FY'22 org growth of 3.8% vs. guidance of 4-6% China reopening likely not a major cons.
Q4 estimate changes Q4'22e is likely to be similar to Q3 in a few ways, with a gross margin below 20...
Svagt kvartal, utdelning bör ge stöd till aktien BE Group rapporterade en underliggande Q4’22 EBIT p...
Major profit warning on component shortages, see SEK 9m in Q4 EBIT Clearly below ABGSCe, likely mate...
Suominen reports Q4 results on Feb 3. It’s clear Q4 will be a lot better than previous quarters, whi...
Order intake up 49% organically, but EBIT 29% below ABGSCe Less able to scale as costs increase; we ...
Fair value range of SEK 9-18 (9-21) Q4e: strong Freemelt ONE sales and an insurance one-off For Q4e,...
En rapport i linje med våra förväntninga Diamyds rapport för det första kvartalet i det brutna räken...
Efterfrågan är gynnsam på samtliga marknader utom Kina Den organiska tillväxten i orderingången var ...
Redeye is favorable to the news that Paxman has received its EU Medical Device Regulation certificat...
VEF took a defensive stance in 2022, focusing on strengthening its balance sheet and reprioritising ...
The most important aspects are organic growth and gross margins in our view.
The strong finish to 2022 was clearly overshadowed by a disappointing 2023 EBITDA margin guidance, ...
CapMan will report its Q4 on 2 February. We expect solid underlying performance, while a quiet trans...
Beijer Group reported an order intake of about SEK603m and sales of close to SEK589m, translating in...
Fortsatt god marknad, marginalerna fortsatte expandera Efterfrågan var generellt god under kvartalet...
Preliminary Q4 sales in line with ABGSCe, EBIT slightly above CEO Christian Sundin leaves after 16 y...
Redeye comments on the first deliveries of the new Carbonhand to patients and is happy to see a good...
Redeye endorses the news that Egetis Therapeutics has conducted a directed share issue of SEK210m an...
